Key result
IV insulin cuts triglycerides ~82% within 60 hours in severe hypertriglyceridemic pancreatitis.
Why the study?
Recognizing hypertriglyceridemia as an etiology of acute pancreatitis and insulin infusion as a treatment modality is important in a resource-limited setting.
Does continuous intravenous insulin infusion effectively reduce serum triglycerides and improve clinical outcomes in a patient with hypertriglyceridemia-induced acute pancreatitis?
Case Report (n=1)
No
Does continuous intravenous insulin infusion effectively reduce serum triglycerides and improve clinical outcomes in a patient with hypertriglyceridemia-induced acute pancreatitis?
Intravenous insulin infusion is an effective, practical, and accessible first-line treatment for rapidly reducing severe hypertriglyceridemia and managing acute pancreatitis, particularly in resource-limited settings.
Answers are grounded in this paper and cite their sources.
Supports insulin infusion as accessible option in resource-limited settings; leaves open need for controlled trials.
A 44‐year‐old man presented with acute abdominal pain and was diagnosed with hypertriglyceridemia‐induced acute pancreatitis. He was managed with fluid resuscitation, analgesia, and insulin infusion and had good recovery. Recognizing hypertriglyceridemia as an etiology of acute pancreatitis and insulin infusion as a treatment modality is important in a resource‐limited setting.
No takes yet. Share an insight, caveat, or question.
Sankhi et al. (2026) conducted a case report in Hypertriglyceridemia-induced acute pancreatitis (n=1). Intravenous insulin infusion was evaluated on Reduction of serum triglycerides and clinical recovery. Continuous intravenous insulin infusion successfully reduced serum triglycerides from /dL to below /dL within 60 hours, leading to clinical recovery from acute pancreatitis.
Synapse has enriched 10 related papers. Consider them for comparative context: